Literature DB >> 10220789

Development of a new sensitive CGRP radioimmunoassay for neuropharmacological research.

J Németh1, T Görcs, Z Helyes, G Oroszi, T Kocsy, E Pintér, J Szolcsányi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10220789

Source DB:  PubMed          Journal:  Neurobiology (Bp)        ISSN: 1216-8068


× No keyword cloud information.
  5 in total

1.  Anti-inflammatory effect of synthetic somatostatin analogues in the rat.

Authors:  Z Helyes; E Pintér; J Németh; G Kéri; M Thán; G Oroszi; A Horváth; J Szolcsányi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents.

Authors:  Z Helyes; E Pintér; J Németh; K Sándor; K Elekes; A Szabó; G Pozsgai; D Keszthelyi; L Kereskai; M Engström; S Wurster; J Szolcsányi
Journal:  Br J Pharmacol       Date:  2006-09-04       Impact factor: 8.739

3.  Comparison of the anti-inflammatory and anti-nociceptive effects of cortistatin-14 and somatostatin-14 in distinct in vitro and in vivo model systems.

Authors:  Adrienn Markovics; Éva Szoke; Katalin Sándor; Rita Börzsei; Teréz Bagoly; Ágnes Kemény; Krisztián Elekes; Erika Pintér; János Szolcsányi; Zsuzsanna Helyes
Journal:  J Mol Neurosci       Date:  2011-06-22       Impact factor: 3.444

4.  Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.

Authors:  Zdravko Lacković; Boris Filipović; Ivica Matak; Zsuzsanna Helyes
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

5.  Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.

Authors:  Zsuzsanna Helyes; Valéria Tékus; Nikolett Szentes; Krisztina Pohóczky; Bálint Botz; Tamás Kiss; Ágnes Kemény; Zsuzsanna Környei; Krisztina Tóth; Nikolett Lénárt; Hajnalka Ábrahám; Emmanuel Pinteaux; Sheila Francis; Serena Sensi; Ádám Dénes; Andreas Goebel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.